Dear Reader,
As we approach the end of 2016, and publish our final issue of Pediatric Drugs for the year, the editors and production staff at Adis wish to reflect on another successful year for the journal and for others in the Adis Premier journals portfolio, and to thank all who have contributed to Pediatric Drugs over the past 12 months.
Mid-2016 saw the release of the ISI Journal Citation Reports and the latest journal impact factors. The impact factor for Pediatric Drugs continues its upwards momentum, with a 5% increase to 2.077. The majority of our other journals also saw a rise in impact factor against the previous year. Most notably, five of our journals saw an increase of over 10% in impact factor–The Patient (17%), Clinical Drug Investigation (16%), the American Journal of Clinical Dermatology (13%), Drug Safety (13.5%), and Drugs (12.5%).
As of October 2016, Pediatric Drugs’ top 10 downloaded articles from SpringerLink this year were:
Psoriasis in Children and Adolescents: Diagnosis, Management and Comorbidities. Bronckers IM, Paller AS, van Geel MJ, van de Kerkhof PC, Seyger MM. Pediatr Drugs. 2015;17(5):373–84.
The use of probiotics in pediatric gastroenterology: a review of the literature and recommendations by Latin-American experts. Cruchet S, Furnes R, Maruy A, Hebel E, Palacios J, Medina F, Ramirez N, Orsi M, Rondon L, Sdepanian V, Xóchihua L, Ybarra M, Zablah RA. Pediatr Drugs. 2015;17(3):199–216.
Management of Functional Constipation in Children: Therapy in Practice. Koppen IJ, Lammers LA, Benninga MA, Tabbers MM. Pediatr Drugs. 2015;17(5):349–60.
Pharmacogenomics in Pediatric Patients: Towards Personalized Medicine. Maagdenberg H, Vijverberg SJ, Bierings MB, Carleton BC, Arets HG, de Boer A, Maitland-van der Zee AH. Pediatr Drugs. 2016;18(4):251–60.
A Qualitative Study into Dependent Relationships and Voluntary Informed Consent for Research in Pediatric Oncology. Dekking SA, van der Graaf R, Schouten-van Meeteren AY, Kars MC, van Delden JJ. Pediatr Drugs. 2016;18(2):145–56.
Bone Sarcomas in Pediatrics: Progress in Our Understanding of Tumor Biology and Implications for Therapy. Rivera-Valentin RK, Zhu L, Hughes DP. Pediatr Drugs. 2015;17(4):257–71.
Pain in Intellectually Disabled Children: Towards Evidence-Based Pharmacotherapy? Valkenburg AJ, de Leeuw TG, van Dijk M, Tibboel D. Pediatr Drugs. 2015;17(5):339–48.
Omalizumab in children. Licari A, Marseglia A, Caimmi S, Castagnoli R, Foiadelli T, Barberi S, Marseglia GL. Pediatr Drugs. 2014;16(6):491–502.
Long-term statin treatment in children with familial hypercholesterolemia: more insight into tolerability and adherence. Braamskamp MJ, Kusters DM, Avis HJ, Smets EM, Wijburg FA, Kastelein JJ, Wiegman A, Hutten BA. Pediatr Drugs. 2015;17(2):159–66.
Clinical features and pharmacotherapy of childhood monoamine neurotransmitter disorders. Ng J, Heales SJ, Kurian MA. Pediatr Drugs. 2014;16(4):275–91.
We offer our sincere thanks to all authors who have contributed articles to Pediatric Drugs over the course of 2016. Their skill and dedication are critical to the continued publication of the journal.
The quality of published articles is, similarly, testament to the significant efforts of the peer reviewers, whose commitment ensures that the journal’s content is held to the highest possible standard. We would like to thank the following individuals who acted as reviewers for articles published in Pediatric Drugs in 2016:
Ishaq Abu-Arafeh, UK
Arash Afshari, Denmark
Karel Allegaert, Belgium
Nicole Almenrader, Italy
Anup Amatya, USA
Richard E. Appleton, UK
Antonio C. Arrieta, USA
Keith J. August, USA
Thomas M. Austin, USA
Tadej Avcin, Slovenia
Craig Bailey, UK
Alexandre Belot, France
John W. Berkenbosch, USA
Frank M.C. Besag, UK
Jeffrey Blumer, USA
Jacob Brogren, Sweden
Francesco Paolo Cantatore, Italy
Joseph B. Cantey, USA
Alberto Chiarugi, Italy
Catherine Chiron, France
Laurent Chouchana, France
Helena L. Coelho, Brazil
Aaron Conway, Australia
James R. Couch Jr, USA
Joseph P. Cravero, USA
Stacy Croteau, USA
Salvatore Cucchiara, Italy
Lydia D’Agostino, USA
Souhayl Dahmani, France
Tiphaine A. de Beaumais, France
Lissy de Ridder, the Netherlands
Stefan De Smedt, Belgium
Alcidesio de Souza Junior, Brazil
Bart De Spiegeleer, Belgium
Elisangela Dellamora, Brazil
Jacques Descotes, France
George A. Diaz, USA
Amalie Dyda, Australia
Eric Dziuban, USA
Richard K. Ellerkmann, Germany
Thomas Engelhardt, UK
Paulo R.B. Evora, Brazil
Fabien G. Eyal, USA
Jay D. Fisher, USA
Julia Freeman, USA
Lawrence K. Fung, USA
Giovanni Gabutti, Italy
Aristea S. Galanopoulou, USA
Jose Garza, USA
Stefan Gebhardt, Germany
Dominique Gendrel, France
Andrew R. Gennery, UK
Jennifer Girotto, USA
Ronald Goldberg, USA
Jennifer L. Goldman, USA
Kenneth R. Goldschneider, USA
Andrew L. Gray, South Africa
Judith Guzman-Cottrill, USA
Benjamin Handen, USA
Henrik Hasle, Denmark
Seth Housman, USA
David Hyun, USA
David Isaacs, Australia
Vanessa Jordan, New Zealand
Robert R.M. Kennedy, USA
James Kidd, USA
Byoung-Ju Kim, Republic of Korea
Yoichiro Kino, Japan
Chad Knoderer, USA
Mukadder U. Kocak, Turkey
Chrysovalantis Korfitis, Greece
Pekka Lahdenne, Finland
Claudia Lanvers-Kaminsky, Germany
J. Bradley Layton, USA
Jacky W.Y. Lee, Hong Kong
Neal LeLeiko, USA
Piet L.J.M. Leroy, the Netherlands
Deborah M. Levy, USA
Byung Gun Lim, Republic of Korea
Jeffrey Lu, USA
David Mandelbaum, USA
Peter Manu, USA
Holly D. Maples, USA
Pierluigi Marzuillo, Italy
Norikazu Matsunaga, Japan
Natalia Maximova, Italy
Ann W. McMahon, USA
Ewan McNicol, USA
Maurizio Miano, Italy
Jorge Morales, Chile
Neil N.S. Morton, UK
Sergey Motov, USA
Wassim Nasreddine, Lebanon
Marcella Nebbioso, Italy
Kristen R. Nichols, USA
Anna Nolan, USA
Tony A.J. Nunn, UK
Ann-Christine Nyquist, USA
Joao B. Oliveira, Brazil
Christophe Orssaud, France
Nathan L. Pace, USA
David Pace, Malta
We would like to take this opportunity to thank retiring Honorary Editorial Board members Professors Dominique Gendrel, David Knoppert and Christopher Kratochvil, and to welcome new members Professors Saskia de Wildt, Emmanuel Roilides and Catherine Sherwin and thank them for their willingness to contribute to the success of Pediatric Drugs. Indeed, we gratefully acknowledge all of the members of the journal’s Honorary Editorial Board, who have acted as peer reviewers and authors, and have provided guidance on journal content, policy and processes:
Marina Aloi, Italy
Stan L. Block, USA
Andrew Bush, UK
Rolando Cimaz, Italy
Saskia de Wildt, the Netherlands
Seymour Diamond, USA
Brian Eley, South Africa
Susanna Esposito, Italy
Robert L. Findling, USA
Dominic Fitzherald, Australia
David A. Gremse, USA
Andreas H. Groll, Germany
Scott A. Halperin, USA
Julian Hamilton-Shield, UK
Gregory L. Holmes, USA
Giorgio Ivani, Italy
Gregory L. Kearns, USA
Gideon Koren, Israel
Desiree Kunac, New Zealand
Zvi Laron, Israel
Stephen Lowis, UK
Stuart MacLeod, Canada
Dinesh K. Mehta, UK
Kathleen A. Neville, USA
Antje Neubert, Germany
Michael E. Pichichero, USA
Emmanuel Roilides, Greece
Catherine M. Sherwin, USA
Robert Sidbury, USA,
William M. Splinter, Canada
Jeffrey A. Towbin, USA
John van den Anker, USA
Hervé Walti, France
Ian C. Wong, UK
Finally, Pediatric Drugs is dedicated to improving the effective and safe use of drugs, including vaccines, in pediatrics, and the Aims and Scope of the journal have been amended slightly to emphasize this.
We hope that you have found the articles published throughout 2016 to be both interesting and informative. We have appreciated the high quality of content contributed to the journal this year and we look forward to keeping you up to date with topical issues in the pediatric pharmacotherapy field in 2017.
With best wishes from the staff at of Pediatric Drugs and all at Adis Publications.
Rights and permissions
About this article
Cite this article
Acknowledgement to Referees. Pediatr Drugs 18, 393–395 (2016). https://doi.org/10.1007/s40272-016-0204-2
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40272-016-0204-2